2005, Number 6
Rev Mex Urol 2005; 65 (6)
Morbidity associated with transrectal ultrasound guided biopsy of the prostate with preparation of extended release ciprofloxacin
Martínez MR, Esteban MJ, Calderón G, Gómez GL, Lozano SJF, Cortés GJR
PDF size: 47.25 Kb.
ABSTRACTBackground. Transrectal ultrasound guided biopsy of the prostate (TRUS biopsy) has been made for many years. The biopsy is a safe procedure but not free of complications. Material and methods. We made a TRUS biopsy in 50 patients after preparation including an enema and three doses of extended release ciprofloxacin administered during three consecutive days. We evaluated the presence of rectal bleeding, hematuria or hematospermia and febrile episodes. Results. Hematuria, rectal bleeding and hematospermia were noted in 36, 64 and 24% of the patients biopsed respectively. In many cases the bleeding was self-limiting. There were no febrile episodes in any patient. The morbidity associated with the biopsy did not require any additional treatment or medical visit. Conclusions. The TRUS biopsy of the prostate is a safe procedure. The preparation with a dose of 1 gram of extended release ciprofloxacin per day for a total of three doses is efficient and easy to take. The infectious and/or hemorrhagic complications are rare and without significance when you use this preparation before the biopsy.